Blackbird Ventures

Blackbird Ventures, established in 2012, is a venture capital firm headquartered in Surry Hills, Australia. The company specializes in investing in early-stage to late-stage startups across diverse sectors, including technology, healthcare, and consumer goods, primarily in Australia and New Zealand. Blackbird's mission is to back ambitious entrepreneurs with transformative ideas, providing them with generational ownership and support throughout their journey from inception to IPO. Notable investments include Canva, Zoox, and CultureAmp.

Alex Apoifis

Partner and COO

Clare Birch

Investment Associate

Robyn Denholm

Operating Partner, Investments

Phoebe Harrop

Partner, Investments

Tom Humphrey

Investor

Silk Kadala

Senior Associate, Investments

Max Meyer

Principal, Investments

James Palmer

Principal, Investments

Tip Piumsomboon

Principal

Michael Tolo

Principal

Mason Yates

Portfolio Analyst

Past deals in 3D Printing

Fleet Space Technologies

Series D in 2024
Fleet Space Technologies is an Australian space technology company that operates a fleet of commercial micro-satellites aimed at transforming critical mineral discovery and space exploration. The company has developed innovative solutions, including the world's first 3D-printed all-metal patch antenna for space, which significantly enhances data throughput. Fleet utilizes its satellite constellation to facilitate the exploration of critical minerals globally and provides satellite-enabled systems and seismic array technology to connect Earth, the Moon, and Mars. By offering low-cost satellite-based systems for Industrial Internet of Things applications, Fleet Space Technologies seeks to revolutionize the mineral exploration and defense sectors while advancing space exploration initiatives.

Gilmour Space

Series D in 2024
Gilmour Space Technologies Pty Ltd is an Australian company established in 2012, based in Pimpama, that specializes in developing low-cost hybrid rockets aimed at the small satellite market. The company focuses on creating hybrid launch vehicles that utilize proprietary 3D printed fuel, allowing for precise control over combustion patterns during ignition. This innovative approach is designed to provide research organizations and clients with a reliable and economical means of launching satellites into low Earth orbit. Gilmour Space is on track to launch its Eris orbital launch vehicles and G-Sat small satellite platforms in 2024.

Fleet Space Technologies

Series C in 2023
Fleet Space Technologies is an Australian space technology company that operates a fleet of commercial micro-satellites aimed at transforming critical mineral discovery and space exploration. The company has developed innovative solutions, including the world's first 3D-printed all-metal patch antenna for space, which significantly enhances data throughput. Fleet utilizes its satellite constellation to facilitate the exploration of critical minerals globally and provides satellite-enabled systems and seismic array technology to connect Earth, the Moon, and Mars. By offering low-cost satellite-based systems for Industrial Internet of Things applications, Fleet Space Technologies seeks to revolutionize the mineral exploration and defense sectors while advancing space exploration initiatives.

Syenta

Seed Round in 2022
Syenta specializes in the 3D printing of multi-material electronics, offering a streamlined fabrication method that reduces steps and minimizes waste. The company's technology allows customers to create and iterate on electronic devices in-house, including sensors, photovoltaics, batteries, printed circuit boards, and antennae. By leveraging electrochemistry, Syenta enables the design and construction of micro-fabricated and nano-fabricated electronics, empowering clients to develop their electronic solutions from virtually any location.

Vexev

Seed Round in 2022
Vexev focuses on developing advanced medical imaging technology aimed at enhancing the diagnosis and monitoring of blood flow patterns in patients. By utilizing non-invasive 3D imaging techniques from ultra-scan systems, Vexev's tools enable clinicians to effectively track and measure the progression of diseases related to veins and arteries. This innovative approach facilitates improved monitoring and prediction of patient outcomes, ultimately contributing to better healthcare management.

Inventia Life

Series B in 2021
Inventia Life Science Pty Ltd is an Australian company founded in 2013 and based in Alexandria. It specializes in 3D bioprinting technology aimed at enhancing cell-based research and clinical applications. The company develops, manufactures, and sells equipment, reagents, and bio-inks—both natural and synthetic—designed for advanced medical research. Inventia's innovative approach focuses on creating low-cost and standardized methods for producing three-dimensional human tissue and organ models. This technology is intended to accelerate cancer research, drug discovery, and advancements in regenerative medicine. By providing a comprehensive suite of hardware, software, consumables, and customized protocols, Inventia Life Science facilitates the flexible production of 3D cell-based assays, significantly impacting the medical research landscape.

Fleet Space Technologies

Series B in 2021
Fleet Space Technologies is an Australian space technology company that operates a fleet of commercial micro-satellites aimed at transforming critical mineral discovery and space exploration. The company has developed innovative solutions, including the world's first 3D-printed all-metal patch antenna for space, which significantly enhances data throughput. Fleet utilizes its satellite constellation to facilitate the exploration of critical minerals globally and provides satellite-enabled systems and seismic array technology to connect Earth, the Moon, and Mars. By offering low-cost satellite-based systems for Industrial Internet of Things applications, Fleet Space Technologies seeks to revolutionize the mineral exploration and defense sectors while advancing space exploration initiatives.

Vexev

Seed Round in 2021
Vexev focuses on developing advanced medical imaging technology aimed at enhancing the diagnosis and monitoring of blood flow patterns in patients. By utilizing non-invasive 3D imaging techniques from ultra-scan systems, Vexev's tools enable clinicians to effectively track and measure the progression of diseases related to veins and arteries. This innovative approach facilitates improved monitoring and prediction of patient outcomes, ultimately contributing to better healthcare management.

Gilmour Space

Series C in 2021
Gilmour Space Technologies Pty Ltd is an Australian company established in 2012, based in Pimpama, that specializes in developing low-cost hybrid rockets aimed at the small satellite market. The company focuses on creating hybrid launch vehicles that utilize proprietary 3D printed fuel, allowing for precise control over combustion patterns during ignition. This innovative approach is designed to provide research organizations and clients with a reliable and economical means of launching satellites into low Earth orbit. Gilmour Space is on track to launch its Eris orbital launch vehicles and G-Sat small satellite platforms in 2024.

Gilmour Space

Series B in 2018
Gilmour Space Technologies Pty Ltd is an Australian company established in 2012, based in Pimpama, that specializes in developing low-cost hybrid rockets aimed at the small satellite market. The company focuses on creating hybrid launch vehicles that utilize proprietary 3D printed fuel, allowing for precise control over combustion patterns during ignition. This innovative approach is designed to provide research organizations and clients with a reliable and economical means of launching satellites into low Earth orbit. Gilmour Space is on track to launch its Eris orbital launch vehicles and G-Sat small satellite platforms in 2024.

Vexev

Pre Seed Round in 2018
Vexev focuses on developing advanced medical imaging technology aimed at enhancing the diagnosis and monitoring of blood flow patterns in patients. By utilizing non-invasive 3D imaging techniques from ultra-scan systems, Vexev's tools enable clinicians to effectively track and measure the progression of diseases related to veins and arteries. This innovative approach facilitates improved monitoring and prediction of patient outcomes, ultimately contributing to better healthcare management.

Gilmour Space

Series A in 2017
Gilmour Space Technologies Pty Ltd is an Australian company established in 2012, based in Pimpama, that specializes in developing low-cost hybrid rockets aimed at the small satellite market. The company focuses on creating hybrid launch vehicles that utilize proprietary 3D printed fuel, allowing for precise control over combustion patterns during ignition. This innovative approach is designed to provide research organizations and clients with a reliable and economical means of launching satellites into low Earth orbit. Gilmour Space is on track to launch its Eris orbital launch vehicles and G-Sat small satellite platforms in 2024.

Fleet Space Technologies

Series A in 2017
Fleet Space Technologies is an Australian space technology company that operates a fleet of commercial micro-satellites aimed at transforming critical mineral discovery and space exploration. The company has developed innovative solutions, including the world's first 3D-printed all-metal patch antenna for space, which significantly enhances data throughput. Fleet utilizes its satellite constellation to facilitate the exploration of critical minerals globally and provides satellite-enabled systems and seismic array technology to connect Earth, the Moon, and Mars. By offering low-cost satellite-based systems for Industrial Internet of Things applications, Fleet Space Technologies seeks to revolutionize the mineral exploration and defense sectors while advancing space exploration initiatives.

Inventia Life

Seed Round in 2017
Inventia Life Science Pty Ltd is an Australian company founded in 2013 and based in Alexandria. It specializes in 3D bioprinting technology aimed at enhancing cell-based research and clinical applications. The company develops, manufactures, and sells equipment, reagents, and bio-inks—both natural and synthetic—designed for advanced medical research. Inventia's innovative approach focuses on creating low-cost and standardized methods for producing three-dimensional human tissue and organ models. This technology is intended to accelerate cancer research, drug discovery, and advancements in regenerative medicine. By providing a comprehensive suite of hardware, software, consumables, and customized protocols, Inventia Life Science facilitates the flexible production of 3D cell-based assays, significantly impacting the medical research landscape.

Gilmour Space

Venture Round in 2016
Gilmour Space Technologies Pty Ltd is an Australian company established in 2012, based in Pimpama, that specializes in developing low-cost hybrid rockets aimed at the small satellite market. The company focuses on creating hybrid launch vehicles that utilize proprietary 3D printed fuel, allowing for precise control over combustion patterns during ignition. This innovative approach is designed to provide research organizations and clients with a reliable and economical means of launching satellites into low Earth orbit. Gilmour Space is on track to launch its Eris orbital launch vehicles and G-Sat small satellite platforms in 2024.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.